Lorundrostat, a selective aldosterone synthase inhibitor, shows blood pressure -lowering potential in people with uncontrolled and treatment-resistant hypertension, according to the Advance-HTN trial. …more
A polygenic risk score could help direct prostate cancer screening towards those at highest risk for the disease, the BARCODE1 investigators report. …more
Elevated total tau in cerebral spinal fluid may indicate initial brain injury in patients with cryptogenic new-onset refractory status epilepticus and predict subsequent hippocampal atrophy, suggest study findings. …more
Antihypertensive treatment of patients over the age of 80 years to a target systolic blood pressure below 130 mmHg could significantly reduce their risk of death from cardiovascular disease by 26%, suggests an analysis of NHANES data. …more
Don’t fall behind!
Get the latest headlines – in your specialties of choice – delivered straight to your inbox.showcase
MEET THE SENIOR TEAM
Lucy Piper
medwireNews Bureau Chief